Author:
Teishima J,Shoji K,Hayashi T,Miyamoto K,Ohara S,Matsubara A
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Urology,Oncology
Reference24 articles.
1. Jin C, Wang F, Wu X, Yu C, Luo Y, McKeehan WL . Directionally specific paracrine communication mediated by epithelial FGF9 to stromal FGFR3 in two-compartment premalignant prostate tumors. Cancer Res 2007; 64: 4555–4562.
2. Wu X, Jin C, Wang F, Yu C, McKeehan WL . Stromal cell heterogeneity in fibroblast growth factor-mediated stromal-epithelial cell cross-talk in premalignant prostate tumors. Cancer Res 2003; 63: 4936–4944.
3. Giri D, Ropiquet F, Ittmann M . FGF9 is an autocrine and paracrine prostatic growth factor expressed by prostatic stromal cells. J Cell Physiol 1999; 180: 53–60.
4. Todo T, Kondo T, Kirino T, Asai A, Adams EF, Nakamura S et al. Expression and growth stimulatory effect of fibroblast growth factor 9 in human brain tumors. Neurosurgery 1998; 43: 337–346.
5. Hendrix ND, Wu R, Kuick R, Schwartz DR, Fearon ER, Cho KR . Ovarian ca wnt Fibroblast growth factor 9 has oncogenic activity and is a downstream target of Wnt signaling in ovarian endometrioid adenocarcinomas. Cancer Res 2006; 66: 1354–1362.